Matches in Wikidata for { <http://www.wikidata.org/entity/Q66391701> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q66391701 description "assaig clínic" @default.
- Q66391701 description "clinical trial" @default.
- Q66391701 description "clinical trial" @default.
- Q66391701 description "clinical trial" @default.
- Q66391701 description "clinical trial" @default.
- Q66391701 description "ensaio clínico" @default.
- Q66391701 description "ensayo clínico" @default.
- Q66391701 description "ensayu clínicu" @default.
- Q66391701 description "essai clinique" @default.
- Q66391701 description "klinisch onderzoek" @default.
- Q66391701 description "клінічне випробування" @default.
- Q66391701 name "PF-06741086 Multiple Dose Study in Severe Hemophilia" @default.
- Q66391701 name "PF-06741086 Multiple Dose Study in Severe Hemophilia" @default.
- Q66391701 type Item @default.
- Q66391701 label "PF-06741086 Multiple Dose Study in Severe Hemophilia" @default.
- Q66391701 label "PF-06741086 Multiple Dose Study in Severe Hemophilia" @default.
- Q66391701 prefLabel "PF-06741086 Multiple Dose Study in Severe Hemophilia" @default.
- Q66391701 prefLabel "PF-06741086 Multiple Dose Study in Severe Hemophilia" @default.
- Q66391701 P1050 Q66391701-7FB9F3D2-7E03-41BD-835B-578E6A35A1B3 @default.
- Q66391701 P1132 Q66391701-9B2B626B-2129-4D69-819D-9E6DCF7A51EF @default.
- Q66391701 P1476 Q66391701-A91B2E84-CDCD-4606-BA71-0D58E6F7CF4D @default.
- Q66391701 P17 Q66391701-11CDC048-1FF3-4964-AC6D-EDBD1B114583 @default.
- Q66391701 P17 Q66391701-2A45A990-3511-42AC-B44E-803823306146 @default.
- Q66391701 P17 Q66391701-379D3D57-3902-4A5D-AF20-27796B9B6C34 @default.
- Q66391701 P17 Q66391701-39764F9B-103E-4F99-93C4-ABAE4FA3129A @default.
- Q66391701 P17 Q66391701-4DDC780F-4C82-4C82-A7ED-7D6A1109601B @default.
- Q66391701 P17 Q66391701-9E0F5FA6-ECDC-4905-B072-B9B7593E0A81 @default.
- Q66391701 P2283 Q66391701-19498A3A-3DE8-4B77-8373-413CBFBCB3CF @default.
- Q66391701 P2899 Q66391701-5FB1FE68-1111-4B8F-8C9C-82EB4E5CE312 @default.
- Q66391701 P3098 Q66391701-D1B2395B-9752-4338-B415-F41B8B733630 @default.
- Q66391701 P31 Q66391701-9463ABD2-0724-4A18-AC4D-7CDF726E34FE @default.
- Q66391701 P4135 Q66391701-E740A1CD-2470-4202-A90A-95A5A8D6CAA3 @default.
- Q66391701 P580 Q66391701-B32F9641-9326-4425-AB37-920BD04C1C64 @default.
- Q66391701 P582 Q66391701-8B3A22CD-CBF3-46B2-B951-5E5E5182BC9E @default.
- Q66391701 P6099 Q66391701-DBE31D3F-5E6B-402E-9878-4F6B7A076C31 @default.
- Q66391701 P8363 Q66391701-EDADC784-7BB7-4B1A-BEC7-8C3409F4B571 @default.
- Q66391701 P859 Q66391701-6BD8DD26-ED43-45EF-90E6-62713F1DD418 @default.
- Q66391701 P1050 Q2092064 @default.
- Q66391701 P1132 "+27" @default.
- Q66391701 P1476 "A Multicenter, Open-label, Multiple Ascending Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Efficacy Of Subcutaneous Or Intravenous Pf-06741086 In Subjects With Severe Hemophilia" @default.
- Q66391701 P17 Q224 @default.
- Q66391701 P17 Q258 @default.
- Q66391701 P17 Q298 @default.
- Q66391701 P17 Q30 @default.
- Q66391701 P17 Q36 @default.
- Q66391701 P17 Q39 @default.
- Q66391701 P2283 Q1755136 @default.
- Q66391701 P2899 "+18" @default.
- Q66391701 P3098 "NCT02974855" @default.
- Q66391701 P31 Q30612 @default.
- Q66391701 P4135 "+64" @default.
- Q66391701 P580 "2017-03-08T00:00:00Z" @default.
- Q66391701 P582 "2018-12-03T00:00:00Z" @default.
- Q66391701 P6099 Q42824440 @default.
- Q66391701 P8363 Q78089383 @default.
- Q66391701 P859 Q206921 @default.